Halder Venture dispatches AGM notice and annual report for FY26

scanx
Reviewed by
Riya DScanX News Team
Key Highlights
  • Halder Venture dispatched AGM notice and annual report for FY26
  • Electronic copies sent to 2,082 shareholders on August 14, 2026
  • Physical weblink letters sent to 566 shareholders without email IDs
  • Dispatch complies with SEBI Listing Regulations Regulation 30
powered bylight_fuzz_icon
49103040

*this image is generated using AI for illustrative purposes only.

Halder Venture Limited has completed the dispatch of its Annual General Meeting (AGM) notice and annual report for FY26 to shareholders.

The company confirmed the dispatch via electronic mode, in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This regulatory filing ensures all members receive the necessary documentation ahead of the meeting.

Dispatch Details

The company utilized electronic channels to reach shareholders with registered email addresses. For those without registered emails, physical letters containing a weblink to access the annual report were sent.

Maheshwari Datamatics Private Limited, acting as the registrar, confirmed the dispatch of the AGM notice and annual report to 2,082 shareholders on August 14, 2026. These documents were sent via email to holders with registered contact details.

Additionally, the company dispatched 566 ordinary post articles. These contained weblink letters intended for shareholders whose email addresses were not registered with the company, registrar, or depository participants. The Department of Posts certified that these items were received and dispatched from the Barabazar Head Post Office in Kolkata on August 14, 2026.

Regulatory Compliance

This intimation is filed under Regulation 30 read with Part-A of Schedule-III of the SEBI Listing Regulations. The company also complied with Regulation 36(1)(b), which mandates providing access to the annual report for shareholders without registered email IDs.

The information is available on the company’s website. Ayanti Sen, Company Secretary and Compliance Officer, signed the disclosure on August 24, 2026.

Historical Stock Returns for Halder Venture

1 Day5 Days1 Month6 Months1 Year5 Years
-1.17%-0.30%+29.88%+19.92%+10.51%+10.51%

What key financial metrics or strategic initiatives are highlighted in Halder Venture's FY26 annual report that could influence investor sentiment?

How might the upcoming AGM resolutions impact Halder Venture's future capital allocation or dividend policy?

Are there any proposed changes to the board of directors or management team expected to be discussed at the AGM?

Halder Venture allots 7.93 lakh warrants to non-promoter group

scanx
Reviewed by
Riya DScanX News Team
Key Highlights

Halder Venture Limited allotted 7,93,650 equity convertible warrants to P.K. Bio Link Private Limited at ₹315 per unit. The deal received regulatory clearances from NSE and BSE and shareholder approval via postal ballot in April 2026.

powered bylight_fuzz_icon
46694353

*this image is generated using AI for illustrative purposes only.

Halder Venture Limited has allotted 7,93,650 equity convertible warrants on a preferential basis to the non-promoter group, marking a key step in its capital raising efforts. The allotment was approved by the Board of Directors during a meeting held on July 24, 2026, and follows prior shareholder consent obtained via postal ballot on April 29, 2026. The move allows the company to raise funds while offering subscription rights for future equity participation to the allottee.

The warrants were issued to P.K. Bio Link Private Limited, categorized as a non-promoter entity. Each warrant carries a face value of ₹10 and was allotted at a price of ₹315 per warrant, which includes a premium of ₹305. The instrument entitles the holder to subscribe for an equivalent number of fully paid-up equity shares of Halder Venture Limited in dematerialized form. The company confirmed that it has already received 25% of the subscription amount from the warrant holder as part of the transaction process.

Transaction Details

The preferential allotment was executed in compliance with regulatory requirements and internal governance protocols. The Board approved the specific terms of the issue, including the pricing and the identity of the allottee. The transaction structure ensures that the warrants are issued in demat form, facilitating ease of transfer and eventual conversion into equity shares.

Allottee Name Category Warrants Allotted Price Per Warrant (₹)
P.K. Bio Link Private Limited Non-Promoter 7,93,650 315

Regulatory Approvals and Compliance

The issuance was conducted pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company had previously secured in-principle approvals from both major stock exchanges. The Bombay Stock Exchange granted approval via Letter no. LOD/PREF/PB/FIP/480/2026-27, while the National Stock Exchange provided approval via Ref: NSE/LIST/54346 dated July 09, 2026.

Shareholder approval for the preferential allotment was obtained through a postal ballot process concluded on April 29, 2026. The Board meeting where the final allotment was approved commenced at 3:00 PM and concluded at 4:15 PM on July 24, 2026. Ayanti Sen, Company Secretary and Compliance Officer of Halder Venture Limited, signed the intimation filed with the exchanges.

What the Numbers Show

The allocation of nearly 8 lakh warrants to a single non-promoter entity indicates a concentrated interest from institutional or high-net-worth investors in Halder Venture’s future equity upside. By setting the warrant price at ₹315 with a ₹305 premium over the ₹10 face value, the company has structured the instrument to reflect significant value beyond nominal capital, aligning the allottee’s interests with the long-term performance of the underlying equity shares.

Historical Stock Returns for Halder Venture

1 Day5 Days1 Month6 Months1 Year5 Years
-1.17%-0.30%+29.88%+19.92%+10.51%+10.51%

How will the eventual conversion of these warrants by P.K. Bio Link Private Limited impact Halder Venture's existing promoter shareholding and control structure?

What specific strategic initiatives or capital expenditures does Halder Venture plan to fund with the proceeds from this warrant issuance?

Given the high premium of ₹305 per warrant, what is the implied conversion price, and how does it compare to the current market price of Halder Venture's equity shares?

More News on Halder Venture

1 Year Returns:+10.51%